CAT and hepatocellular carcinoma: In addition, with highest pathways scores observed, Cat-GS is also significantly enriched in normal liver tissues compared to HCC in all the datasets (Figure 1B), suggesting that the gene signature (Cat-GS) we developed has greater sensitivity and specificity to identify HCC onset and progression compared to any other gene set representing individual metabolic pathways.